Dr. Jean-Yves Parisot, in his first address as Symrise CEO, welcomed nearly 350 shareholders at the Annual General Meeting in Holzminden on May 15, 2024. He thanked his predecessor, Dr. Heinz-Jürgen Bertram, and presented an overview of Symrise’s development and strategy.
Stable Financial Performance and Growth
Parisot highlighted stable organic sales growth of nearly 8% for the 2023 fiscal year despite global uncertainties. Both divisions, Taste, Nutrition & Health, and Scent & Care, saw significant growth. For 2024, Symrise projects organic growth of 5-7%, with a notable 11% increase in first-quarter sales compared to the previous year. An efficiency program worth EUR 50 million aims to boost profitability.
Sustainability Commitment
Parisot emphasized Symrise's commitment to sustainability, aiming for net-zero status by 2045.
Shareholder Votes
Shareholders approved all agenda items, including profit appropriation, board discharges, auditor appointments, remuneration report approval, virtual AGM amendments, and new capital authorizations. Detailed voting results are available at Symrise AGM.
